Achilles Tendinopathy: A Surgical Reference Guide
Introduction & Epidemiology
Achilles tendinopathy, often colloquially referred to as "tendinitis," encompasses a spectrum of conditions affecting the Achilles tendon, ranging from acute inflammatory responses (true tendinitis) to chronic degenerative changes within the tendon (tendinosis) and inflammation of the surrounding paratenon (paratenonitis). The term "tendinopathy" is increasingly preferred as it accurately reflects the predominant histopathological finding of collagen disorganization, cellular matrix degeneration, and neovascularization, rather than a purely inflammatory process, especially in chronic cases. This condition significantly impairs function and can lead to considerable morbidity for affected individuals.
The Achilles tendon, formed by the conjoined aponeuroses of the gastrocnemius and soleus muscles, is the strongest and thickest tendon in the human body, capable of withstanding forces up to 10 times body weight during vigorous activities. It is a critical structure for propulsion, gait, and ankle stability.
Epidemiology:
Achilles tendinopathy is a prevalent condition, particularly among athletes involved in running, jumping, and explosive activities, but also affects the sedentary population.
*
Incidence:
Varies widely, reported as high as 7-9% in recreational runners annually, with lifetime prevalence estimates in athletes approaching 25-30%. The general population incidence is lower but not insignificant.
*
Risk Factors:
*
Intrinsic:
*
Age:
Increased incidence with advancing age, peaking in individuals between 30 and 50 years, likely due to cumulative microtrauma and decreased tendon vascularity/healing capacity.
*
Gender:
Predominantly male in athletic populations, though female athletes are also affected.
*
Obesity:
Higher body mass index (BMI) places increased mechanical load on the tendon.
*
Foot Type/Biomechanics:
Pes planus, pes cavus, limited ankle dorsiflexion, excessive pronation can alter load distribution and increase stress on the Achilles tendon.
*
Systemic Conditions:
Diabetes mellitus, hypertension, dyslipidemia are associated with altered tendon metabolism and increased risk. Seronegative spondyloarthropathies (e.g., ankylosing spondylitis, psoriatic arthritis) can cause inflammatory enthesopathy.
*
Genetic Predisposition:
Polymorphisms in genes encoding collagen type I and V have been implicated in susceptibility.
*
Extrinsic:
*
Overuse/Training Errors:
Rapid increases in training intensity, duration, or frequency; insufficient recovery; sudden changes in running surfaces (e.g., from soft to hard). This remains the most common precipitating factor.
*
Improper Footwear:
Worn-out shoes, shoes lacking adequate support, or those with minimal heel drop can increase tendon strain.
*
Medications:
Fluoroquinolone antibiotics (e.g., ciprofloxacin, levofloxacin) are a well-documented risk factor for Achilles tendinopathy and rupture, even with short-term use. Systemic corticosteroids and local corticosteroid injections near the tendon can also compromise tendon integrity.
Pathophysiology:
The traditional view of "tendinitis" implying inflammation has largely been superseded by understanding "tendinosis" as a degenerative process. Histological studies of chronic Achilles tendinopathy reveal:
* Disorganized collagen fibers, with a decrease in collagen type I and an increase in type III.
* Increased cellularity with an abundance of tenocytes and myofibroblasts.
* Increased ground substance (proteoglycans, glycosaminoglycans).
* Neovascularization and neo-innervation within the tendon.
* Absence of a significant inflammatory infiltrate in chronic cases.
This degenerative cascade is thought to be initiated by repetitive microtrauma exceeding the tendon's reparative capacity, leading to a failed healing response rather than an acute inflammatory process.
Surgical Anatomy & Biomechanics
A thorough understanding of the Achilles tendon's anatomy and biomechanics is paramount for successful surgical management of its pathologies.
Surgical Anatomy
The Achilles tendon is a complex structure formed by the confluence of three muscles: the medial gastrocnemius, lateral gastrocnemius, and soleus.
*
Muscles of Origin:
*
Gastrocnemius:
Biarticular muscle originating from the posterior aspects of the medial and lateral femoral condyles, contributing significantly to knee flexion and ankle plantarflexion.
*
Soleus:
Uniarticular muscle originating from the posterior aspect of the fibular head, the proximal third of the fibula, and the soleal line of the tibia, primarily involved in ankle plantarflexion.
*
Confluence and Spiral Twist:
The aponeuroses of the gastrocnemius and soleus typically merge in the mid-calf region, forming the Achilles tendon proper. Notably, the fibers undergo a counterclockwise spiral twist (in the right leg, clockwise in the left) of approximately 90 degrees as they descend, with the gastrocnemius fibers becoming more lateral and the soleus fibers more medial and anterior at the insertion. This spiral configuration is thought to optimize tensile strength and elastic energy storage.
*
Dimensions:
The Achilles tendon is typically 15-20 cm long and 5-6 mm thick, broadening to about 1.5 cm at its insertion.
*
Insertion:
The tendon inserts into the posterior aspect of the calcaneus, covering an area approximately 2-3 cm superior to the calcaneal tuberosity. The superior-most fibers typically insert at the posterosuperior prominence of the calcaneus, an area often involved in Haglund's deformity. The enthesis is a fibrocartilaginous zone that transitions from tendon to bone.
*
Paratenon:
The Achilles tendon is enveloped by a richly vascularized paratenon, a loose connective tissue layer that allows frictionless gliding. Unlike tendons with true synovial sheaths, the Achilles tendon does not possess one. The paratenon contributes significantly to the tendon's blood supply.
*
Blood Supply:
The Achilles tendon has a relatively robust blood supply from the musculotendinous junction proximally and the osseo-tendinous junction distally, with contributions from the paratenon along its length. However, a "watershed" or relatively hypovascular zone exists approximately 2-6 cm proximal to its calcaneal insertion. This region is a common site for both tendinopathy and rupture, potentially due to its comparatively poorer vascularity and higher mechanical stresses.
*
Innervation:
Primarily from branches of the tibial nerve, which also innervate the gastrocnemius and soleus. The sural nerve (branch of the tibial nerve), which provides sensation to the posterolateral lower leg and lateral foot, runs superficially and posterolaterally to the Achilles tendon. It is highly susceptible to injury during posteromedial or posterior surgical approaches and must be carefully identified and protected.
*
Adjacent Structures:
*
Retrocalcaneal Bursa:
A true synovial bursa located between the anterior surface of the Achilles tendon and the posterior-superior aspect of the calcaneus. Inflammation here (retrocalcaneal bursitis) is common, often associated with insertional tendinopathy and Haglund's deformity.
*
Superficial Calcaneal Bursa:
Located between the skin and the posterior aspect of the Achilles tendon. Less commonly involved.
*
Plantaris Tendon:
A small, thin tendon often found running medial to the Achilles tendon. While anatomically distinct, it can sometimes be used as an autograft in Achilles reconstruction.
Biomechanics
The Achilles tendon is critical for efficient bipedal locomotion.
*
Primary Function:
Powerful plantarflexion of the ankle, essential for push-off during walking, running, and jumping. The gastrocnemius also assists in knee flexion.
*
Load Bearing:
During walking, the Achilles tendon can be subjected to forces of 3-5 times body weight. During running and jumping, these forces can increase to 6-10 times body weight.
*
Elastic Energy Storage:
The tendon acts as a spring, storing elastic energy during dorsiflexion (e.g., during the stance phase of gait) and releasing it during plantarflexion, contributing to efficient movement and reducing metabolic cost.
*
Stiffness and Compliance:
The tendon's material properties, including its stiffness and compliance, allow it to transmit muscle forces effectively while also absorbing shock. Tendinopathy can alter these properties, reducing the tendon's ability to store and release energy, thereby impacting biomechanical efficiency and increasing injury risk.
*
Impact of Tendinopathy:
Degenerative changes associated with tendinopathy (collagen disorganization, altered ground substance) result in a stiffer, less compliant, and weaker tendon, predisposing it to further injury and rupture. The relative hypovascular zone also experiences maximal tensile and shear stresses during ankle motion, making it particularly vulnerable.
Indications & Contraindications
Surgical intervention for Achilles tendinopathy is generally considered a last resort, reserved for patients who have failed an extensive, structured course of non-operative management.
Indications for Operative Management
The decision to proceed with surgery is multifaceted, incorporating the duration and severity of symptoms, the extent of tendon pathology, and the patient's functional demands.
1. Non-Insertional Achilles Tendinopathy (usually 2-6 cm proximal to insertion):
*
Chronic Pain and Dysfunction:
Persistent, debilitating pain for at least 3-6 months (often 6-12 months) despite adequate non-operative treatment.
*
Failed Non-Operative Treatment:
Documented failure of comprehensive, supervised conservative measures, including:
* Eccentric loading rehabilitation protocols (e.g., Alfredson protocol).
* Activity modification and relative rest.
* Physical therapy (stretching, strengthening, modalities).
* Orthotics or shoe modifications (heel lifts, arch supports).
* Non-steroidal anti-inflammatory drugs (NSAIDs).
* Platelet-rich plasma (PRP) injections or other biological treatments (with variable evidence).
* Extracorporeal shockwave therapy (ESWT).
*
Imaging Findings:
MRI demonstrating significant intratendinous degeneration, thickening, collagen disorganization, neovascularization, or areas of mucoid degeneration. Palpable intratendinous nodule or thickening.
*
Functional Impairment:
Inability to perform activities of daily living, work, or sport due to pain and stiffness.
2. Insertional Achilles Tendinopathy (at the calcaneal insertion):
*
Chronic Pain and Dysfunction:
Similar to non-insertional, pain lasting >6 months despite comprehensive non-operative treatment.
*
Failed Non-Operative Treatment:
As above, with a particular emphasis on addressing any associated biomechanical factors.
*
Imaging Findings:
* Radiographs demonstrating intratendinous calcification, ossification, or a Haglund's deformity (posterosuperior calcaneal prominence).
* MRI confirming retrocalcaneal bursitis, intratendinous degeneration/calcification, and assessing the integrity of the tendon insertion.
*
Haglund's Deformity:
Symptomatic Haglund's deformity causing chronic retrocalcaneal bursitis and/or impingement on the Achilles tendon.
Contraindications for Operative Management
While relative, these factors warrant careful consideration and may preclude or delay surgical intervention.
*
Acute Inflammatory Phase:
Surgery is generally contraindicated during acute tendinitis; non-operative treatment is pursued initially.
*
Uncontrolled Systemic Medical Comorbidities:
*
Poorly controlled Diabetes Mellitus:
Increases risk of infection, wound healing complications, and impaired tendon healing.
*
Peripheral Vascular Disease:
Compromises wound healing and increases risk of complications.
*
Significant Immunosuppression:
Due to medications or systemic conditions, elevating infection risk.
*
Active Local or Systemic Infection.
*
Unrealistic Patient Expectations:
Regarding surgical outcomes, recovery timelines, or return to high-level activities.
*
Lack of Adherence to Post-Operative Rehabilitation:
A critical component for successful outcomes; patients unwilling or unable to commit are poor surgical candidates.
*
Severe Atrophy of Calf Musculature:
May compromise the functional outcome of debridement or augmentation.
*
Prior Extensive Surgery in the Region:
May lead to significant scarring, altered anatomy, and increased risk of neurovascular injury.
*
Smoking:
A significant risk factor for poor wound healing and impaired tendon repair. Aggressive smoking cessation counseling is essential pre-operatively.
Operative vs. Non-Operative Indications
| Feature / Indication | Non-Operative Management | Operative Management |
|---|---|---|
| Duration of Symptoms | Acute (days to few weeks) to Subacute (1-3 months), sometimes chronic if responding. | Chronic (>6 months, often >12 months) |
| Response to Initial Treatment | Good or partial response to conservative measures. | Failure of comprehensive, supervised conservative measures. |
| Severity of Pain / Dysfunction | Mild to moderate pain, manageable functional limitations. | Severe, debilitating pain impacting ADLs, work, or sport. Significant functional impairment. |
| Imaging Findings | Tendon thickening, minor degenerative changes. No significant Haglund's deformity or large calcifications. | Significant intratendinous degeneration (MRI), palpable nodule/thickening. Symptomatic Haglund's deformity with retrocalcaneal bursitis, intratendinous calcification/ossification (X-ray, MRI). |
| Tendon Integrity (MRI) | Intact tendon or minimal interstitial tears. | Significant tendon degeneration, >50% cross-sectional involvement, impending rupture, or partial tears not responding to conservative care. |
| Patient Demographics | All patients initially. | Patients without major contraindications, willing to commit to rehabilitation. |
Pre-Operative Planning & Patient Positioning
Careful pre-operative planning and meticulous patient positioning are crucial for minimizing complications and optimizing surgical outcomes in Achilles tendinopathy.
Pre-Operative Planning
-
Comprehensive History and Physical Examination:
- Detail history of pain, onset, duration, aggravating/alleviating factors, previous treatments, and functional limitations.
- Assess for systemic conditions (diabetes, autoimmune disorders, fluoroquinolone use).
- Palpate the Achilles tendon for tenderness, thickening, nodules, or defects.
- Evaluate ankle range of motion (especially dorsiflexion), calf strength, and gait.
- Specific tests for Haglund's deformity (e.g., palpation, pump bump).
- Neurovascular assessment.
-
Imaging Review:
- Plain Radiographs (AP, lateral, oblique views of ankle and foot): Essential for identifying bony spurs (Haglund's deformity), posterior calcaneal cortical irregularity, intratendinous calcification or ossification, and ruling out other bony pathologies.
- Magnetic Resonance Imaging (MRI): The gold standard for soft tissue evaluation. It accurately delineates the extent of tendon degeneration, assesses for partial tears, intratendinous calcification, retrocalcaneal bursitis, paratenonitis, and can help differentiate between insertional and non-insertional pathology. It is critical for surgical planning, especially when considering the need for augmentation.
- Ultrasound: Dynamic, cost-effective, and excellent for assessing tendon thickness, identifying areas of degeneration, neovascularization, and paratenonitis. Can be operator-dependent.
-
Surgical Strategy Formulation:
-
Based on clinical and imaging findings, determine the most appropriate surgical approach:
- Non-insertional tendinopathy: Debridement of degenerative tissue +/- paratenonectomy. If significant defect (>50% of tendon volume), consider augmentation (e.g., FHL transfer).
- Insertional tendinopathy: Excision of Haglund's deformity, debridement of retrocalcaneal bursa, debridement of intratendinous calcification, and reattachment of the Achilles tendon (if detached). Augmentation may be required for significant tendon defects.
- Ancillary Procedures: Consider gastrocnemius recession if significant equinus contracture is present, particularly in non-insertional cases.
-
Based on clinical and imaging findings, determine the most appropriate surgical approach:
-
Patient Counseling:
- Thorough discussion of the proposed procedure, expected outcomes, potential complications (wound healing, nerve injury, re-rupture, residual pain), and the critical importance of prolonged, structured post-operative rehabilitation.
- Manage expectations regarding return to activity levels.
- Review smoking cessation, DVT prophylaxis, and antibiotic prophylaxis protocols.
-
Operating Room Logistics:
- Ensure appropriate instruments are available (osteotomes, high-speed burr for Haglund's, tendon passers, suture anchors).
- Availability of tourniquet, electrocautery, appropriate suture material (non-absorbable for tendon repair).
- Consider nerve stimulator if FHL transfer is planned.
Patient Positioning
The prone position is standard and provides optimal access to the posterior aspect of the ankle and Achilles tendon.
-
Preparation:
- Patient is placed supine for induction of anesthesia and placement of a high thigh tourniquet (if used). Ensure adequate padding under the tourniquet.
- The patient is then carefully turned to the prone position.
-
Prone Positioning Considerations:
- Head Support: Head should be placed on a horseshoe headrest or foam donut, ensuring neutral cervical spine alignment and avoiding pressure on facial structures or eyes.
- Chest Support: Pillows or chest rolls are placed under the chest to allow for adequate diaphragmatic excursion and reduce abdominal pressure, minimizing bleeding.
- Arm Positioning: Arms can be tucked at the sides with elbows flexed to 90 degrees and forearms pronated, or extended on arm boards, ensuring no pressure on nerves or vessels.
-
Lower Extremity Positioning:
- A roll or pillow is placed under the distal tibia/shin to slightly elevate the foot and allow for neutral ankle positioning or slight plantarflexion, providing clearance for the foot and access to the posterior heel. This also prevents pressure on the anterior tibia.
- Careful padding of pressure points (knees, anterior pelvis, iliac crests).
- Ensure the ipsilateral hip is in neutral rotation to prevent undue tension on the limb.
-
Sterile Prep and Drape:
- The limb is prepped from the mid-calf to the toes, including the entire foot.
- Draping should allow for full visualization of the Achilles tendon and calcaneus, as well as unrestricted manipulation of the ankle and foot to assess tendon tension and range of motion during the procedure. An adhesive incise drape is often used.
- A sterile stockinette can be applied to the foot to aid in manipulation.
-
Tourniquet Inflation: After draping, the tourniquet is inflated to the appropriate pressure. A timed tourniquet strategy is advisable.
Detailed Surgical Approach / Technique
Surgical techniques for Achilles tendinopathy aim to debride degenerative tissue, address any associated bony impingement, and, if necessary, augment the tendon's structural integrity. The specific approach varies depending on whether the pathology is non-insertional or insertional.
General Principles for all Approaches
- Longitudinal Incision: Minimized risk of skin necrosis compared to transverse incisions.
- Sural Nerve Protection: Critical, especially with lateral or midline approaches. Identify and protect throughout the dissection.
- Careful Soft Tissue Handling: Minimize retraction, use sharp dissection.
- Hemostasis: Meticulous control of bleeding to maintain a clear surgical field.
- Debridement of Diseased Tissue: Excise all non-viable, degenerative tissue until healthy, glistening, white tendon is encountered.
- Augmentation Threshold: Consider augmentation if more than 50% of the tendon cross-sectional area is debrided.
1. Non-Insertional Achilles Tendinopathy (Open Debridement)
This is typically performed for chronic tendinosis located 2-6 cm proximal to the calcaneal insertion.
A. Incision:
*
Midline Posterior Incision:
A longitudinal incision, typically 8-12 cm in length, centered over the area of maximal thickening or tenderness. This provides direct access but necessitates careful identification and protection of the sural nerve, which is usually found posterolaterally.
*
Medial Paratendinous Incision:
A longitudinal incision just medial to the Achilles tendon. Offers good access and potentially lower risk of sural nerve injury (as the nerve is lateral).
*
Lateral Paratendinous Incision:
A longitudinal incision just lateral to the Achilles tendon. Often preferred by surgeons due to the consistently lateral course of the sural nerve, making it easier to identify and protect by retracting it laterally.
B. Dissection & Exposure:
1.
Skin and Subcutaneous Tissue:
Incise sharply. Achieve meticulous hemostasis.
2.
Sural Nerve Identification:
With a lateral or midline approach, carefully identify the sural nerve as it typically crosses the lateral aspect of the Achilles tendon in the distal third of the calf. Use gentle blunt dissection and vessel loops for retraction.
3.
Paratenon Incision:
Incise the paratenon longitudinally over the area of tendinopathy. The paratenon may appear thickened, inflamed, or hypervascular. Carefully elevate it from the underlying tendon. Assess for paratenonitis; if severe, a paratenonectomy may be performed.
4.
Tendon Inspection:
The diseased tendon appears yellowish, grayish, soft, swollen, and lacks the normal glistening white appearance of healthy tendon. Neovascularization may be evident.
C. Debridement:
1.
Excision of Degenerative Tissue:
Using a #15 blade, systematically excise all visible degenerative, necrotic, and discolored tendon tissue. Continue until only healthy, firm, white, bleeding tendon is encountered.
2.
Longitudinal Tenotomies:
Some surgeons perform multiple longitudinal tenotomies (releasing incisions) through healthy tendon at the edges of the debridement to promote neovascularization and healing.
3.
Assessment of Defect:
Carefully assess the size and depth of the resultant tendon defect. If more than 50% of the cross-sectional area of the tendon is debrided, augmentation is typically indicated.
D. Augmentation (if indicated):
*
Flexor Hallucis Longus (FHL) Tendon Transfer:
The most common and robust augmentation technique.
*
Harvest:
A separate medial incision may be used, or the posterior incision extended. The FHL tendon is identified deep to the flexor digitorum longus (FDL) in the tarsal tunnel area. It is harvested proximally, ensuring its muscle belly is left intact.
*
Transfer:
The FHL tendon is passed through a drill hole in the calcaneus (transcalcaneal tunnel) from posterior to anterior, or woven directly into the remaining Achilles tendon stump. It can be passed through the remaining Achilles tendon from medial to lateral and then secured back onto itself (side-to-side repair) or brought through another transosseous tunnel.
*
Fixation:
Securely fix the FHL tendon to the calcaneus (e.g., with bioabsorbable interference screw in the bone tunnel) or to the remaining Achilles tendon using strong, non-absorbable sutures in a Pulvertaft weave or similar configuration. The ankle should be in slight plantarflexion during fixation to minimize tension.
*
Plantaris Tendon Graft:
If the plantaris tendon is robust, it can be harvested and used as a local autograft for augmentation, woven into the debrided Achilles.
*
Gastrocnemius Recession/Lengthening:
If a significant gastrocnemius contracture is present (often assessed pre-operatively with the Silfverskiöld test), a gastrocnemius recession may be performed through the same or a separate incision to reduce tension on the Achilles tendon.
E. Closure:
1.
Paratenon:
If healthy, the paratenon may be loosely approximated with absorbable sutures to aid gliding and revascularization. If severely diseased, it may be partially excised.
2.
Subcutaneous Tissue and Skin:
Closed in layers using absorbable sutures for subcutaneous tissue and non-absorbable sutures or staples for the skin.
2. Insertional Achilles Tendinopathy (Debridement with Calcaneal Excision/Augmentation)
This approach addresses pathology directly at the calcaneal insertion, often associated with Haglund's deformity and retrocalcaneal bursitis.
A. Incision:
*
Midline Posterior Incision:
Longitudinal, typically 8-12 cm, centered over the Achilles insertion. Allows direct access to the posterior calcaneus and Achilles tendon. The sural nerve is protected by retracting it laterally.
B. Dissection & Exposure:
1.
Skin and Subcutaneous Tissue:
Incise and achieve hemostasis.
2.
Sural Nerve:
Identify and protect the sural nerve as it courses laterally.
3.
Tendon Detachment:
*
Partial Detachment:
A "tongue" of Achilles tendon (medial or lateral) can be left attached to the calcaneus to preserve some continuity and facilitate reattachment. The central portion of the tendon is detached from its insertion.
*
Complete Detachment:
If extensive degeneration or calcification involves the entire footprint, the tendon may need to be completely detached from the calcaneus. Make a beveled cut, leaving a small cuff of tendon for reattachment, if possible.
4.
Retrocalcaneal Bursa:
The inflamed retrocalcaneal bursa is identified between the tendon and the calcaneus. It is typically excised to relieve inflammation.
C. Calcaneal Osteotomy (Haglund's Excision):
1.
Identification:
The posterosuperior calcaneal prominence (Haglund's deformity) causing impingement is identified.
2.
Resection:
Using an osteotome or a high-speed burr, carefully resect the prominent bony spur. The goal is to create a smooth, rounded posterior calcaneal contour without sharp edges, extending slightly inferiorly and laterally to ensure adequate decompression of the tendon. Typically, 5-10 mm of bone is resected.
3.
Fluoroscopy:
Intraoperative fluoroscopy can be used to confirm adequate bone resection and clear the impingement zone.
D. Tendon Debridement & Reattachment:
1.
Debridement:
Remove all intratendinous calcification and degenerative tendon tissue. Debride until healthy tendon is visualized.
2.
Calcaneal Preparation:
Prepare the insertion site on the calcaneus by decorticating the bone to create a bleeding bed for tendon-to-bone healing.
3.
Tendon Reattachment:
*
Suture Anchors:
The most common method. Two or more non-absorbable suture anchors are placed into the posterior calcaneus (just distal to the excised prominence). The sutures are then passed through the detached Achilles tendon in a locking fashion.
*
Transosseous Tunnels:
Drill multiple small tunnels through the calcaneus (from posterior to anterior). Non-absorbable sutures are passed through the tendon and then through these tunnels, tied over a bone bridge or directly to the tendon superiorly.
*
Fixation:
With the ankle positioned in slight plantarflexion (typically 15-20 degrees), the sutures are meticulously tied down to securely reattach the tendon to the calcaneus, ensuring firm apposition.
E. Augmentation (if indicated):
* Similar to non-insertional tendinopathy, if the tendon defect after debridement and reattachment is substantial (>50% cross-sectional area or concerns about repair integrity), an FHL tendon transfer is the preferred method of augmentation. The FHL tendon is harvested and woven into the reconstructed Achilles, passed through a transcalcaneal tunnel, and secured.
F. Closure:
1.
Paratenon:
Loosely approximate the paratenon, if possible, but avoid overtightening.
2.
Subcutaneous Tissue and Skin:
Closed in layers.
Internervous Planes & Critical Structures
While distinct internervous planes (like those in joint arthroplasty) are not strictly utilized, maintaining awareness of critical neurovascular structures is paramount:
*
Sural Nerve:
The most commonly injured nerve. Its course is posterolateral to the Achilles tendon. During posterior midline approaches, it should be identified early, traced, and protected by retracting it laterally. Using a lateral paratendinous incision can help minimize its exposure but still requires careful dissection.
*
Small Saphenous Vein:
Runs with the sural nerve and should be identified and protected or ligated if necessary.
*
Posterior Tibial Neurovascular Bundle:
Located deep and medial to the Achilles tendon in the tarsal tunnel. Generally not at risk during superficial Achilles surgery, but awareness is important during deeper dissections (e.g., FHL harvest).
Complications & Management
Surgical intervention for Achilles tendinopathy, while effective, carries inherent risks. A thorough understanding of potential complications and their management is essential for optimizing patient care.
Common Complications and Salvage Strategies
| Complication | Incidence | Etiology / Contributing Factors | Management / Salvage Strategy |
|---|---|---|---|
| 1. Wound Healing Issues | 5-20% (higher in smokers, diabetics, steroid users) | Hematoma, infection, tension, devascularization, systemic comorbidities (diabetes, PVD, smoking, obesity, corticosteroids). | Superficial: Local wound care, serial debridement, antibiotics. Deep: Surgical debridement, IV antibiotics, wound VAC. Necrosis/Dehiscence: Aggressive debridement, flap coverage (local rotation flaps, free flaps for large defects), secondary intention healing. Optimize systemic factors. |
| 2. Sural Nerve Injury | 5-15% (paresthesia, dysesthesia, numbness) | Direct transection, traction, entrapment in scar tissue. More common with lateral or posteromedial incisions/retraction. | Paresthesia/Numbness: Observation, gabapentin/pregabalin for neuropathic pain. Persistent Symptoms/Painful Neuroma: Neurolysis, neuroma excision with or without nerve grafting (rarely). Complete Transection: Primary repair if possible, nerve grafting. |
| 3. Achilles Tendon Rupture (Post-Op) | 2-5% (early or late) | Early: Inadequate repair/fixation, premature weight-bearing, aggressive rehabilitation, poor tissue quality. Late: Re-rupture due to persistent tendinopathy, trauma, or inadequate healing. | Early: Surgical re-exploration, direct repair with stronger fixation (e.g., Krackow stitch), often requires augmentation (FHL transfer). Late: Similar to acute rupture management; reconstruction with autograft (FHL) or allograft is often necessary. |
| 4. Persistent Pain / Failure to Improve | 10-25% | Incomplete debridement, missed pathology (e.g., missed Haglund's, undiagnosed subtle tear), persistent biomechanical issues, poor rehabilitation adherence, complex regional pain syndrome (CRPS), chronic pain syndrome. | Thorough clinical re-evaluation, repeat advanced imaging (MRI) to identify residual pathology. Aggressive physical therapy, pain management consultation. Consider revision surgery if identifiable and addressable cause. |
| 5. Ankle Stiffness / Limited ROM | 5-10% | Scar tissue formation, inadequate rehabilitation, re-fibrosis, over-aggressive repair, prolonged immobilization. | Intensive physical therapy focusing on ROM and stretching. Manipulation under anesthesia for severe cases. Tenolysis or scar excision (rarely). |
| 6. Calf Weakness | Up to 10-15% (especially after significant debridement or FHL transfer) | Loss of contractile force from debrided tendon, donor site morbidity (FHL transfer), muscle atrophy from immobilization. | Progressive strengthening exercises as part of rehabilitation. Gradual return to activity. Patient education regarding potential for some persistent weakness. |
| 7. Deep Venous Thrombosis (DVT) / Pulmonary Embolism (PE) | <1% with prophylaxis | General surgical risk, prolonged immobilization. | Prophylaxis: Chemical (LMWH, aspirin) and mechanical (TED hose, IPCs). Management: Anticoagulation for DVT/PE. IVC filter for contraindications to anticoagulation or recurrent PE. |
| 8. Complex Regional Pain Syndrome (CRPS) | <1% | Idiopathic; possibly related to nerve injury, severe pain, or psychological factors. | Early diagnosis is key. Multidisciplinary pain management, physical therapy, nerve blocks, sympathetic blocks, psychological support. |
| 9. Osseous Impingement / Inadequate Haglund's Resection (Insertional only) | 2-5% | Incomplete removal of posterior calcaneal prominence. | Revision surgery to complete the Haglund's osteotomy. |
| 10. Donor Site Morbidity (FHL Transfer) | Rare | Hallux rigidus, hallux weakness, hammertoe, nerve injury (medial plantar nerve). | Physical therapy, orthotics. Surgical intervention for persistent hallux deformity (e.g., MTP fusion, tendon transfer). |
General Principles for Managing Complications:
*
Early Recognition:
Prompt identification of complications is critical.
*
Aggressive Management:
Do not delay appropriate intervention.
*
Multidisciplinary Approach:
Involve infectious disease specialists, wound care nurses, pain management specialists, and vascular surgeons as needed.
*
Patient Education and Support:
Maintain open communication with the patient regarding the nature of the complication, treatment plan, and expected outcomes.
Post-Operative Rehabilitation Protocols
Post-operative rehabilitation is a cornerstone of successful surgical outcomes for Achilles tendinopathy. A structured, progressive, and individualized protocol is essential to optimize healing, restore function, and prevent recurrence. The protocol generally involves phases of protection, controlled motion, progressive strengthening, and return to activity.
Phase I: Protection and Immobilization (Weeks 0-2/4)
Goals:
Protect the repair, minimize swelling, control pain, prevent wound complications.
*
Immobilization:
*
0-2 weeks:
Non-weight-bearing (NWB) in a rigid cast or controlled ankle motion (CAM) boot with the ankle positioned in approximately 15-30 degrees of plantarflexion to minimize tension on the repair.
*
2-4 weeks (if tolerated):
May progress to touch-down weight-bearing (TDWB) or partial weight-bearing (PWB) in the CAM boot, maintaining plantarflexion.
*
Pain & Swelling Management:
* Elevation of the limb above the heart.
* Ice application (cryotherapy).
* Prescribed analgesics.
*
Early Motion:
* Gentle toe flexion/extension exercises to promote circulation and prevent stiffness in the forefoot.
* Non-weight-bearing core and hip strengthening exercises.
*
Wound Care:
Meticulous wound care, monitoring for signs of infection. Suture/staple removal typically at 2 weeks.
Phase II: Controlled Motion and Early Strengthening (Weeks 2/4 - 6/8)
Goals:
Gradual increase in weight-bearing, controlled range of motion, initiate gentle strengthening.
*
Weight-Bearing Progression:
*
Week 2-4:
Progress from TDWB to PWB in CAM boot with a gradual reduction in plantarflexion (e.g., using heel wedges) as tolerated.
*
Week 4-6/8:
Progress to full weight-bearing (FWB) in CAM boot, gradually increasing dorsiflexion (removing heel wedges, typically 0-10 degrees of dorsiflexion by week 6-8).
*
Range of Motion (ROM):
*
Active ROM:
Begin gentle active ankle dorsiflexion (to neutral initially), plantarflexion, inversion, eversion (in CAM boot or out of boot if allowed).
*
Passive ROM:
Gentle passive stretching,
avoiding excessive dorsiflexion initially
(limit to neutral or slight dorsiflexion up to 6 weeks).
*
Strengthening:
* Isometric calf contractions (gentle, in plantarflexion).
* Hip and knee strengthening (e.g., straight leg raises, hamstring curls).
* Theraband exercises for ankle inversion/eversion, plantarflexion (gentle resistance).
*
Scar Management:
Gentle massage to prevent adhesions and improve tissue mobility once the incision is healed.
Phase III: Progressive Strengthening and Proprioception (Weeks 6/8 - 12/16)
Goals:
Restore full pain-free ROM, improve calf strength, enhance balance and proprioception.
*
Mobility:
* Transition out of CAM boot and into a supportive shoe with a heel lift (e.g., 1-2 cm) to reduce initial Achilles tension.
* Continue working towards full pain-free ankle ROM, emphasizing dorsiflexion.
*
Strengthening:
* Progressive resisted exercises for calf musculature: seated calf raises, standing calf raises (bilateral, then unilateral as tolerated).
* Introduction of eccentric calf loading exercises (e.g., Alfredson protocol modified for post-surgical recovery), starting with both legs for rising and a single leg for lowering, progressing to single leg for both.
* Leg press, step-ups, lunges.
*
Proprioception and Balance:
* Single-leg standing balance.
* Balance board exercises, wobble board training.
* Dynamic balance activities.
*
Gait Training:
Normalize gait pattern without compensatory strategies.
Phase IV: Return to Activity / Sport-Specific Training (Weeks 12/16 - 6+ Months)
Goals:
Achieve maximal strength, power, agility, and safe return to pre-injury activity levels.
*
Advanced Strengthening:
* Plyometric exercises (low-level jumps, hopping, box jumps).
* Agility drills (shuttle runs, figure-eights).
* Increased resistance for calf strengthening exercises.
* Sports-specific drills and training simulations.
*
Cardiovascular Conditioning:
Swimming, cycling, elliptical training.
*
Gradual Return to Running:
Begin with short intervals of walking/running, progressively increasing duration and intensity, avoiding hills initially.
*
Criteria for Return to Sport:
* Full pain-free ankle ROM.
* Calf strength (e.g., single-leg heel raise endurance) at least 90% of the unaffected limb.
* Successful completion of functional hop tests and agility drills without pain or apprehension.
* Absence of swelling or tenderness.
* Psychological readiness.
*
Long-Term Maintenance:
Continue a structured strengthening and stretching program indefinitely to prevent recurrence.
Key Considerations
- Individualization: Protocols must be tailored to the individual patient's pathology, surgical procedure, healing capacity, and functional goals.
- Communication: Close communication between the surgeon, physical therapist, and patient is paramount for successful progression.
- Pain as a Guide: While some discomfort is expected, sharp or increasing pain warrants re-evaluation and potential temporary regression in the protocol.
- Eccentric Loading: Introduction of eccentric loading is crucial but must be carefully timed and progressed due to the stress it places on the healing tendon.
- Duration: Full recovery and return to sport often take 6-12 months, or even longer, especially after extensive reconstruction (e.g., FHL transfer).
Summary of Key Literature / Guidelines
The literature on Achilles tendinopathy is extensive, but high-level evidence (Level I and II randomized controlled trials) for surgical management remains somewhat limited, particularly for specific techniques. Much of the current understanding and surgical practice relies on Level III and IV studies, expert consensus, and clinical experience.
Key Principles from Literature:
- Non-Operative Management First-Line: There is a broad consensus that non-operative management, particularly eccentric loading protocols, is the initial and preferred treatment strategy for all types of Achilles tendinopathy. Alfredson et al.'s work in the late 1990s and early 2000s significantly popularized and validated the eccentric calf-raise protocol, demonstrating good long-term outcomes (up to 90% success in some series for non-insertional tendinopathy).
- Surgical Indication for Failed Conservative Care: Surgery is consistently indicated for chronic tendinopathy that has failed at least 3-6 months (and often longer, up to 12 months) of supervised, comprehensive non-operative treatment.
-
Pathology-Specific Approach:
- Non-Insertional Tendinopathy: Surgical debridement of the degenerative tissue (tendinosis) and removal of any paratenonitis is the mainstay. Outcomes are generally good, with success rates often reported between 70-90%.
- Insertional Tendinopathy: Requires addressing both the tendon pathology and any bony impingement (Haglund's deformity). Excision of the posterosuperior calcaneal prominence, debridement of intratendinous calcification, and excision of retrocalcaneal bursitis are critical. Outcomes are generally favorable, though potentially with a slightly higher complication rate compared to non-insertional cases due to the need for bony work and often tendon detachment/reattachment.
-
Augmentation for Large Defects:
The literature supports augmentation of the Achilles tendon when significant portions (e.g., >50% cross-sectional area) are debrided.
- Flexor Hallucis Longus (FHL) Tendon Transfer: Numerous studies have established FHL transfer as the gold standard for Achilles tendon augmentation, particularly in cases of chronic insertional tendinopathy with large defects or re-ruptures. It provides a robust and reliable source of viable tendon with acceptable donor site morbidity. Success rates are high, often exceeding 85%, though full recovery can be prolonged.
- Other augmentation options, such as synthetic grafts or other autografts (e.g., plantaris, peroneus brevis), have been reported but are less commonly used for primary augmentation of chronic tendinopathy defects compared to FHL.
- Role of Gastrocnemius Recession: For patients with concomitant gastrocnemius contracture, gastrocnemius recession can reduce tension on the Achilles tendon and improve outcomes, particularly in recalcitrant cases.
- Minimally Invasive Approaches: Endoscopic or percutaneous techniques for debridement or Haglund's resection have been described, offering potential benefits of smaller incisions and faster recovery. However, these techniques require specific expertise and may have limitations in the extent of debridement or augmentation possible, and their long-term comparative efficacy with open approaches is still evolving.
- Biological Treatments (PRP, Stem Cells): While popular, the evidence for biological augmentation (e.g., platelet-rich plasma, stem cell injections) in chronic Achilles tendinopathy, either alone or as adjuncts to surgery, remains mixed and largely inconclusive. Most high-quality studies have not demonstrated a clear superior benefit over placebo or conventional treatment. Their routine use in surgical protocols is not universally recommended.
- Post-Operative Rehabilitation: The importance of a prolonged, progressive, and supervised rehabilitation protocol is universally emphasized. Early controlled mobilization, followed by gradual weight-bearing and progressive strengthening (especially eccentric loading), is crucial for optimal healing and return to function. Non-adherence to protocols is a significant risk factor for poor outcomes.
Clinical Guidelines:
Several orthopedic societies (e.g., American Academy of Orthopaedic Surgeons - AAOS, British Orthopaedic Association) have published clinical practice guidelines or consensus statements that reinforce these principles, consistently advocating for initial non-operative management and reserving surgery for refractory cases with clear pathological indications. These guidelines typically emphasize shared decision-making with patients, considering their activity levels, comorbidities, and expectations.
Future Directions:
Research continues to focus on:
* Elucidating the precise pathophysiology of tendinopathy to develop more targeted non-operative and operative treatments.
* Improving imaging techniques for early and accurate diagnosis.
* Evaluating the long-term efficacy and cost-effectiveness of various surgical and non-surgical interventions.
* Exploring regenerative medicine strategies with higher levels of evidence.
* Optimizing post-operative rehabilitation protocols for faster, safer return to high-level function.